FDA-Approved Juvederm Voluma XC Produces Lasting Results for Up to Two Years
The FDA has approved Juvederm Voluma XC for age-related volume loss in the mid-face region. During a clinical trial, results lasted up to two years. Because the aging process causes the cheek area to lose its suppleness, skin may begin to sag. Fillers and injectables, such as Juvederm Voluma XC, offer a non-surgical option of...